Dr. Reddy's Labs Files 6-K
Ticker: RDY · Form: 6-K · Filed: Oct 29, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
DRL filed a 6-K, standard reporting for foreign issuers.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on October 29, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations company and files its annual reports under Form 20-F.
Why It Matters
This filing indicates ongoing compliance and reporting for Dr. Reddy's Laboratories as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000650 (filing_id) — Accession Number
- 20251029 (date) — Filing Date
- Hyderabad, India (location) — Principal Executive Office
FAQ
What type of company is Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited is classified under the Standard Industrial Classification code 2834, which represents Pharmaceutical Preparations.
Where is Dr. Reddy's Laboratories Limited's principal executive office located?
The principal executive office of Dr. Reddy's Laboratories Limited is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the SEC file number for Dr. Reddy's Laboratories Limited?
The SEC file number for Dr. Reddy's Laboratories Limited is 001-15182.
Does Dr. Reddy's Laboratories Limited file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Limited indicates that it files annual reports under cover of Form 20-F.
What is the purpose of this Form 6-K filing?
This Form 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed in October 2025.
Filing Stats: 398 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-10-29 09:57:53
Filing Documents
- rdy0816_6k.htm (6-K) — 49KB
- rdy0816_ex99-1.htm (EX-99.1) — 24KB
- rdy0816_ex99-1img01.jpg (GRAPHIC) — 3KB
- rdy0816_ex99-1img02.jpg (GRAPHIC) — 10KB
- 0001575872-25-000650.txt ( ) — 92KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: October 29, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary